UK - Foreign, Commonwealth and Development Office (FCDO)
COVID-19 vaccine funding for the COVAX Advance Market Commitment using IFFIm.
Project Data Last Updated: 16/02/2021
IATI Identifier: GB-GOV-1-301271
The UK is supporting early access to COVID-19 vaccines for the world’s poorest countries through a commitment to the COVAX AMC (Advance Market Commitment) using the International Financing Facility for Immunisation (IFFIm). This contribution will support access to at least 1 billion vaccine doses during 2021 for 92 developing countries. This will contribute to ending the acute phase of the COVID-19 pandemic by reducing morbidity and mortality. Supporting access for the world poorest countries demonstrates UK commitment to vaccine multilateralism and supports the UK’s international objectives of bringing the pandemic under control and supporting global economic recovery.
Sectors groups as a percentage of country budgets according to the Development Assistance Committee's classifications.
A comparison across six financial years of forecast spend and the total amount of money spent on the project to date.
ODA measures in relation to their realisation of OECD development policy objectives